Pseudohypocalcemia caused by perchlorate (Irenat (R)) by Durner, Juergen et al.
Clin Chem Lab Med 2011;49(4):665–667  2011 by Walter de Gruyter • Berlin • New York. DOI 10.1515/CCLM.2011.113
2010/540
Article in press - uncorrected proof
Pseudohypocalcemia caused by perchlorate (Irenat)
Ju¨rgen Durner1, Ursula Winkler-Budenhofer2,
Simon Gahr2, Walter Samtleben2 and
Ulf Scho¨nermarck2,*
1 Institute of Clinical Chemistry, University Hospital
Munich-Grosshadern, Ludwig-Maximilians-University,
Munich, Germany
2 Nephrology Division, Department I of Internal Medicine,
University Hospital Munich-Grosshadern, Ludwig-
Maximilians-University, Munich, Germany
Abstract
Background: Blood gas analysis (BGA), including meas-
urement of ionized calcium, is performed routinely in
patients with end stage renal disease on renal replacement
therapy, especially when using citrate for regional anticoa-
gulation. After installation of a new blood gas analyzer
(RAPIDpoint 405; BGA), we observed lower ionized cal-
cium concentrations in a few patients without signs of hypo-
calcemia, whereas calcium concentrations were normal using
a standard laboratory method. Pseudohypocalcemia was of
limited duration and correlated with the short-term intake of
sodium perchlorate monohydrate (Irenat).
Methods: We prepared dilution series from whole blood
samples and stock solutions of calcium and perchlorate with
different concentrations of ionized calcium and perchlorate.
Measurement of ionized calcium concentrations was per-
formed using two different blood gas analyzers (RAPID-
point 405; BGA and Roche AVL 9180; standard laboratory
method).
Results: After addition of different amounts of perchlorate,
significant lower ionized calcium concentrations were meas-
ured with BGA compared to the standard laboratory method
using either preparations from whole blood samples or stock
solutions. The addition of potassium or methylene blue
known to complex perchlorate had no effect on the concen-
trations of ionized calcium measured with BGA. Using dif-
ferent mathematical methods, a calculation of the ‘‘real’’
ionized calcium concentration from the value measured with
BGA was not possible.
Conclusions: Based on our experiments, we confirm the
hypothesis that perchlorate can influence the measurement of
ionized calcium by BGA. As the effect depends on the ion
selective electrode that is used, it is advisable to test the
blood gas analyzer with calcium and perchlorate solutions.
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Introduction
Blood gas analysis (BGA), including measurement of acid-
base status, electrolytes and ionized calcium is regularly per-
formed in patients with end stage renal disease (ESRD)
undergoing regular intermittent hemodialysis treatment or
patients with acute renal failure on continuous renal replace-
ment therapy. The frequent measurement of ionized calcium
is even more essential when using citrate for regional anti-
coagulation in patients with high-risk of bleeding.
During the past few years, ionized calcium concentrations
were measured in our hospital bedside with a point-of-care
BGA system using ion selective electrodes (ISEs). After
changing to another BGA device, we observed in a few
patients with ESRD on regular hemodialysis treatment, a
sudden and unexpected development of very low concentra-
tions of ionized calcium, although these patients showed no
clinical signs of hypocalcemia (Table 1). When checking the
calcium concentrations by our hospital laboratory that used
standard laboratory methods, normal concentrations of ion-
ized and total calcium were found, suggesting that the pseu-
dohypocalcemia measured with the BGA was probably due
to an interfering substance. Furthermore, we observed an
increase in ionized calcium concentrations during each
hemodialysis session in these patients. Viewing the medica-
tion list, we noticed a temporal relationship with the devel-
opment of hypocalcemia and the intake of sodium
perchlorate monohydrate (Irenat). Therefore, we tested the
hypothesis that perchlorate might influence the measurement
of ionized calcium in our new BGA system.
Materials and methods
A stock solution of calcium gluconate (B. Braun, Melsungen, Ger-
many) was prepared with 0.9% NaCl (B. Braun) at a concentration
of 2.5 mmol/L ionized calcium. A stock solution of sodium per-
chlorate monohydrate (Irenat; Bayer, Leverkusen, Germany) was
prepared with 0.9% NaCl at a concentration of 2.45 mmol/L per-
chlorate (ClO4-). Under the assumption that a patient with a weight
of 75 kg and a blood volume of 6 L received 45 drops Irenat
orally, which were completely absorbed, and that perchlorate has a
volume of distribution of 0.34 L/kg (1), a serum perchlorate con-
centration of 0.3 mmol/L can be estimated. Higher serum concen-
trations would be expected with higher doses, a lower volume of
distribution, repeated drug dosing and accumulation due to renal
insufficiency.
Measurement of ionized calcium was performed with a RAPID-
point 405 Blood Gas Analyzer (Siemens Healthcare Diagnostics,
Munich, Germany; referred to as BGA) and with a Roche AVL 9180
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Table 1 Blood samples from three patients with end-stage renal disease on regular hemodialysis treatment receiving perchlorate for a short
period of time because of a radiologic examination with iodine-containing contrast medium. The ionized and total calcium concentrations
were measured before, during and after perchlorate intake with the routine laboratory method (Lab) compared to the blood gas analyzer
RAPIDpoint 405 (BGA).
Patient Before During After
Ionized Ca2q Ionized Ca2q Perchlorate intake Total Ca2q Ionized Ca2q
(BGA), mmol/L (BGA), mmol/L Ionized Ca2q (Lab), mmol/L (BGA), mmol/L
(Lab), mmol/L
1 1.05 0.33 0.91 1.70 1.07
2 1.09 0.49 1.17 2.01 1.06
3 1.15 0.42 1.20 2.43 1.15
Table 2 Measured ionized calcium concentrations with the laboratory method (Lab) compared to the blood gas analyzer RAPIDpoint
405 (BGA). Samples contain different concentrations of ionized calcium and perchlorate. Data are shown as the mean. The CV was -7.5%
and is not included in order to simplify the Table. aSignificant differences between measured and expected ionized calcium concentrations.
(A) The concentration of ionized calcium in the sample from stock solution is listed in column one (expected Ca2q). The concentration
of perchlorate in the sample is listed in row two.
Expected Perchlorate, mmol/L
Ca2q, mmol/L 1.2 0.9 0.6 0.3 0.15 0.075
Lab BGA Lab BGA Lab BGA Lab BGA Lab BGA Lab BGA
0.8 0.84 0.28a 0.85 0.34a 0.84 0.44a 0.84 0.56a 0.88 0.66a 0.85 0.64a
1.0 1.02 0.44a 1.02 0.21a 1.04 0.25a 1.02 0.67a 1.02 0.79a 1.01 0.87
1.2 1.20 0.29a 1.22 0.51a 1.20 0.68a 1.14 0.92a 1.20 1.11 1.2 1.25
1.4 1.38 0.45a 1.37 0.56a 1.37 0.44a 1.38 1.00a 1.37 1.22 1.37 1.38
(B) The concentration of ionized calcium in whole blood samples from two healthy donors is listed in column one (expected Ca2q). The
same amounts of perchlorate were added as in (A). Because perchlorate likely will not reach equilibrium across the red blood cell memb-
rane very quickly, the plasma concentration of perchlorate in the sample is higher. The effective plasma concentration of perchlorate after
volume correction of whole blood samples according to the hematocrit is listed in row two.
Expected Perchlorate, mmol/L
Ca2q, mmol/L 2.3 1.7 1.1 0.6 0.29 0.143
Lab BGA Lab BGA Lab BGA Lab BGA Lab BGA Lab BGA
1.26 (Donor 1) 1.27 0.34a 1.29 0.50a 1.30 0.64a 1.31 0.63a 1.31 0.75a 1.33 1.06a
1.20 (Donor 2) 1.27 0.26a 1.29 0.37a 1.29 0.53a 1.32 0.76a 1.31 0.96a 1.33 1.06a
Electrolyte Analyzer from the routine laboratory in our hospital
(Roche Diagnostics, Basel, Switzerland; laboratory method). Both
systems measure ionized calcium with an ISE.
In the first set of experiments, different concentrations of ionized
calcium and perchlorate were prepared by mixing the stock solu-
tions. The obtained concentrations are given in Table 2. In a second
set of experiments, native whole blood samples from two healthy
volunteers, taking no pharmaceuticals, were mixed with the per-
chlorate stock solution to obtain the concentrations given in Table
2. In a third set of experiments, KCl (concentration of stock solu-
tions: 4.0 mmol/L, 1.0 mol/L or 4.4 mol/L) or methylene blue (sat-
urated solution) (Merck, Darmstadt, Germany) were added to
samples with ionized calcium and perchlorate. From both substances
it is known that they can complex perchlorate (2, 3). In a fourth set
of experiments, dilution series from stock solutions of ionized cal-
cium and perchlorate were prepared.
The measured ionized calcium values from BGA and laboratory
method were analyzed with different mathematical models (forma-
tion of quotients, exponential regression, polynomial regression) to
determine a correction algorithm.
Statistical analysis of significance was performed using the paired
sample t-test, corrected according to Bonferroni-Holm. p-0.05 was
considered to be significant. All values are presented as means of
the measured ionized calcium"SD (standard deviation) from ns4
independent experiments.
Results
After preparation of samples with different concentrations of
ionized calcium and perchlorate, significant lower concen-
trations of ionized calcium were measured with BGA com-
pared to the laboratory method (Table 2A). At ionized
calcium concentrations of 0.8 and 1.0 mmol/L and at the
lowest tested perchlorate concentration (0.075 mmol/L), sig-
nificant lower ionized calcium concentrations were measured
with BGA compared to the laboratory results (Table 2A).
Multiple measurements lead to the same results within the
limits of ionized calcium measurements of 7.5%, with
respect to the guidelines of the German Medical Association
Panel for Quality Control in Medical Laboratory Investiga-
tions (4).
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A similar result was obtained using whole blood samples
from two healthy volunteers. Donor 1 had an ionized calcium
of 1.26 mmol/L and donor 2 of 1.20 mmol/L measured with
the BGA. The hematocrit was 48% in donor 1 and 47% in
donor 2. After addition of different amounts of a concen-
trated perchlorate stock solution to whole blood samples, sig-
nificant lower ionized calcium concentrations were measured
with BGA compared to the laboratory result (Table 2B). The
measurement of sodium and potassium with both BGA and
the laboratory method was not influenced by addition of
perchlorate.
The addition of various concentrations of potassium as
well as the addition of a saturated solution of methylene blue
had no effect on the concentrations of ionized calcium meas-
ured with the BGA and were therefore not able to normalize
the measured calcium concentrations (data not shown).
Analyzing the measured values from BGA and the routine
laboratory method with different mathematical models, it
was not possible to find a correction factor or an algorithm
to calculate the ‘‘real’’ ionized calcium value from the meas-
ured one with the BGA.
Discussion
After implementation of a new BGA device using a different
ISE (RAPIDpoint 405), we noticed a temporal profound
reduction in ionized calcium concentrations in a few patients
with ESRD on regular hemodialysis treatment. These
patients showed no clinical signs of hypocalcemia and had
previously normal ionized calcium concentrations. Measure-
ment of ionized and total calcium concentrations with the
routine laboratory method revealed normal results, although
both analyzing systems used ISEs. Therefore, pseudohypo-
calcemia was diagnosed which was of limited duration and
correlated well with the prescription of sodium perchlorate
monohydrate.
Perchlorate (Irenat) is widely used to prevent thyroid
dysfunction after administration of iodine-containing contrast
medium (5). Studies in humans and animals revealed that
perchlorate is excreted unchanged via the kidney, with a half-
life of approximately 6 h (6, 7). Therefore, in renal insuffi-
ciency, perchlorate can accumulate, although usually without
side effects during short-term application.
The results of our experiments verified the hypothesis that
sodium perchlorate influences the measurement of ionized
calcium in the BGA (RAPIDpoint 405) that we used. We
could show that this effect was measurable even at very low
perchlorate concentrations, which are easily achieved in
patients with accumulation of perchlorate due to renal insuf-
ficiency. Meanwhile, a similar, but less pronounced distur-
bance of ionized calcium measurements has also been noted
with certain blood gas analyzing systems from a different
manufacturer. Without knowledge of the specific structure of
the membrane used in different ISE, the mechanisms of inter-
ference with perchlorate remain unclear.
In the dilution series with different concentrations of ion-
ized calcium and perchlorate, we could show that it is not
possible to find a simple correction factor or an algorithm to
calculate the ‘‘real’’ ionized calcium concentration from the
measured value with our BGA system. The observed
increase in ionized calcium concentrations during each
hemodialysis session can be explained by the fact that per-
chlorate was removed during hemodialysis (8). Furthermore,
we were not able to antagonize the perchlorate effect in the
blood samples with the addition of potassium or methylene
blue, which have been used to measure perchlorate by form-
ing sparingly soluble complexes (2, 3).
In summary, unexplained hypocalcemia in BGA should
prompt the clinician to search for possible interacting sub-
stances. Our study supports the hypothesis that sodium per-
chlorate (Irenat) can interfere with the measurement of
ionized calcium. The effect depends on the ISE used in the
analyzing system. A calculation of the ‘‘real’’ ionized cal-
cium concentration from the value measured with BGA is
not possible. Thus, it is advisable to test the analyzing system
on the clinical ward with stock solutions of ionized calcium
(in the range of 1.0–1.4 mmol/L) and perchlorate (0.6–
1.2 mmol/L) to see if the measurement of ionized calcium
is affected.
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